Parker BS - Search Results

1

Encapsulation of Mitoxantrone within Cucurbit[8]uril Decreases Toxicity and Enhances Survival in a Mouse Model of Cancer.

Konda SK, Maliki R, McGrath S, Parker BS, Robinson T, Spurling A, Cheong A, Lock P, Pigram PJ, Phillips DR, Wallace L, Day AI, Collins JG, Cutts SM. Konda SK, et al. Among authors: parker bs. ACS Med Chem Lett. 2017 Apr 24;8(5):538-542. doi: 10.1021/acsmedchemlett.7b00090. eCollection 2017 May 11. ACS Med Chem Lett. 2017. PMID: 28523107 Free PMC article.

2

Formation of DNA adducts by formaldehyde-activated mitoxantrone.

Parker BS, Cullinane C, Phillips DR. Parker BS, et al. Nucleic Acids Res. 1999 Jul 15;27(14):2918-23. doi: 10.1093/nar/27.14.2918. Nucleic Acids Res. 1999. PMID: 10390534 Free PMC article.

3

Formaldehyde activation of mitoxantrone yields CpG and CpA specific DNA adducts.

Parker BS, Cutts SM, Cullinane C, Phillips DR. Parker BS, et al. Nucleic Acids Res. 2000 Feb 15;28(4):982-90. doi: 10.1093/nar/28.4.982. Nucleic Acids Res. 2000. PMID: 10648792 Free PMC article.

4

Cytosine methylation enhances mitoxantrone-DNA adduct formation at CpG dinucleotides.

Parker BS, Cutts SM, Phillips DR. Parker BS, et al. J Biol Chem. 2001 May 11;276(19):15953-60. doi: 10.1074/jbc.M009216200. Epub 2001 Feb 13. J Biol Chem. 2001. PMID: 11278477 Free article.

5

Structural requirements for the formation of anthracycline-DNA adducts.

Cutts SM, Parker BS, Swift LP, Kimura KI, Phillips DR. Cutts SM, et al. Among authors: parker bs. Anticancer Drug Des. 2000 Oct;15(5):373-86. Anticancer Drug Des. 2000. PMID: 11354313

6

Mitoxantrone mediates demethylation and reexpression of cyclin d2, estrogen receptor and 14.3.3sigma in breast cancer cells.

Parker BS, Cutts SM, Nudelman A, Rephaeli A, Phillips DR, Sukumar S. Parker BS, et al. Cancer Biol Ther. 2003 May-Jun;2(3):259-63. doi: 10.4161/cbt.2.3.364. Cancer Biol Ther. 2003. PMID: 12878861

7

A molecular understanding of mitoxantrone-DNA adduct formation: effect of cytosine methylation and flanking sequences.

Parker BS, Buley T, Evison BJ, Cutts SM, Neumann GM, Iskander MN, Phillips DR. Parker BS, et al. J Biol Chem. 2004 Apr 30;279(18):18814-23. doi: 10.1074/jbc.M400931200. Epub 2004 Feb 12. J Biol Chem. 2004. PMID: 14963025 Free article.

8

Formation of mitoxantrone adducts in human tumor cells: potentiation by AN-9 and DNA methylation.

Parker BS, Rephaeli A, Nudelman A, Phillips DR, Cutts SM. Parker BS, et al. Oncol Res. 2004;14(6):279-90. doi: 10.3727/096504003773994815. Oncol Res. 2004. PMID: 15206490

9

Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-cell Antitumor Function in Multiple Models of Breast Cancer.

Rautela J, Baschuk N, Slaney CY, Jayatilleke KM, Xiao K, Bidwell BN, Lucas EC, Hawkins ED, Lock P, Wong CS, Chen W, Anderson RL, Hertzog PJ, Andrews DM, Möller A, Parker BS. Rautela J, et al. Among authors: parker bs. Cancer Immunol Res. 2015 Nov;3(11):1207-17. doi: 10.1158/2326-6066.CIR-15-0065. Epub 2015 Jul 21. Cancer Immunol Res. 2015. PMID: 26198985

10

Neoadjuvant Interferons: Critical for Effective PD-1-Based Immunotherapy in TNBC.

Brockwell NK, Owen KL, Zanker D, Spurling A, Rautela J, Duivenvoorden HM, Baschuk N, Caramia F, Loi S, Darcy PK, Lim E, Parker BS. Brockwell NK, et al. Among authors: parker bs. Cancer Immunol Res. 2017 Oct;5(10):871-884. doi: 10.1158/2326-6066.CIR-17-0150. Epub 2017 Aug 28. Cancer Immunol Res. 2017. PMID: 28848054

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

64 results

Search Page